fda import alert green list glp-1 semaglutide tirzepatide 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our badge: 6 Month Supply Grind:Whole Bean New Study: GLP-1s REDUCED

fda import alert green list glp-1 semaglutide tirzepatide 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our badge: 6 Month Supply Grind:Whole Bean New Study: GLP-1s REDUCED

New Study: GLP-1s REDUCED Depression Risk by 42% #glp1 #glp1weightloss

Eli Lilly is awaiting an FDA decision on a new indication for Mounjaro covering the reduction of major adverse cardiovascular events in patients with type 2 diabetes, supported by the SURPASS CVOT trial

badge: 6 Month Supply

Grind:Whole Bean

Always check the medication upon arrival at your destination